mutual funds hdfc pharma and healthcare fund directgrowth

holdings

HDFC Pharma And Healthcare Fund Direct-Growth

Equity: Sectoral-Pharma - Growth (Open ended)

HDFC Pharma And Healthcare Fund Direct-GrowthNAV: 20.99 as on 07 Jul, 2026

Risk levelCategoryBenchmark

Factsheet

SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: BSE Healthcare Total Return Index

NAV: ₹20.99-1.07%

08 Jul 2026

Holdings Analysis

Equity, debt and cash allocation snapshot with market cap distribution for HDFC Pharma And Healthcare Fund Direct-Growth.

Asset Allocation

As on 31 May 2026

Equity

98.68%

Others

1.32%

Market Cap Distribution

Large Cap (27.8%)

Mid Cap (34.7%)

Small Cap (37.5%)

Historical Asset Allocation

Asset	31 May 2026	30 Apr 2026	31 Mar 2026	28 Feb 2026	31 Jan 2026	31 Dec 2025
Equity	98.68%	97.30%	98.52%	98.22%	97.34%	97.80%
Debt	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Others (incl. cash)	1.32%	2.70%	1.48%	1.78%	2.66%	2.20%
Commodities	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Real Estate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Portfolio Snapshot

No. of Securities

P/E Ratio

45.83

P/B Ratio

6.02

Top Holding %

9.20%

Top 5 Holdings %

33.11%

Top 10 Holdings %

54.54%

AUM

₹2,362 Cr

Expense Ratio

1.15%

Since Inception

30.81%

Max Drawdown

-0.15%

Top Portfolio Holdings by Weight

Latest portfolio holdings sorted by allocation weight. Includes instrument name, sector, number of shares, market value (₹ Cr) and percentage of net assets. Switch dates or categories using the controls below.

Instrument	Sector	No. of Shares	Value (Rs. Cr)	Weight	Change
Sun Pharmaceutical Industries Ltd.	Healthcare	12,08,549	217.44	9.20%	1.15%↑
Divis Laboratories Ltd.	Healthcare	2,84,087	189.4	8.02%	-0.54%↓
Lupin Ltd.	Healthcare	5,68,274	128.87	5.45%	-0.62%↓
Max Healthcare Institute Ltd.	Healthcare	12,88,696	124.37	5.26%	-0.67%↓
Aster DM Healthcare Ltd.	Healthcare	16,81,027	122.44	5.18%	-0.28%↓
Cipla Ltd.	Healthcare	8,30,035	116.29	4.92%	0.65%↑
Acutaas Chemicals Ltd.	Healthcare	3,39,010	106.19	4.50%	0.43%↑
Alkem Laboratories Ltd.	Healthcare	1,87,494	103.08	4.36%	-0.33%↓
Anthem Biosciences Ltd.	Healthcare	12,91,629	98.16	4.15%	-0.40%↓
Ipca Laboratories Ltd.	Healthcare	5,41,736	82.58	3.50%	-0.89%↓
Fortis Healthcare Ltd.	Healthcare	8,66,882	80.49	3.41%	-0.30%↓
Glenmark Pharmaceuticals Ltd.	Healthcare	3,40,887	77.55	3.28%	-2.78%↓
Laurus Labs Ltd.	Healthcare	5,49,343	74.82	3.17%	0.37%↑
Krishna Institute of Medical Sciences Ltd	Healthcare	9,84,676	74.72	3.16%	0.12%↑
Global Health Ltd.	Healthcare	6,11,964	72.76	3.08%	0.87%↑
Neuland Laboratories Ltd.	Healthcare	41,218	70.43	2.98%	1.01%↑
Vijaya Diagnostic Centre Ltd.	Healthcare	4,88,093	63.87	2.70%	0.15%↑
Metropolis Healthcare Ltd.	Healthcare	10,81,488	60.06	2.54%	0.15%↑
Zydus Lifesciences Ltd.	Healthcare	5,48,897	59.15	2.50%	-
Wockhardt Ltd.	Healthcare	2,83,279	57.55	2.44%	0.77%↑

1 / 2

Sector-wise Portfolio Allocation

Equity exposure by sector as a percentage of total net assets, tracked across recent portfolio dates. Identifies concentration risk and sector rotation trends in the fund's holdings.

Sector	31 May 2026	30 Apr 2026	31 Mar 2026	28 Feb 2026	31 Jan 2026	31 Dec 2025
Healthcare	98.68%	97.30%	98.52%	98.22%	97.34%	97.80%

Equity Insights

A detailed look at the equity holdings of this scheme — aggregated scores on value, momentum, quality parameters along with diversification and performance analysis.

Style Analysis

Value score

23.7 / 100

Weighted average Value score is 23.7. This indicates that portfolio is relatively overvalued using composite of value measures.

Price Momentum score

80.8 / 100

Weighted average Price Momentum score is 80.8. This indicates that portfolio has high momentum using composite of momentum measures.

Quality score

87.3 / 100

Weighted average Quality score is 87.3. This indicates that portfolio has high quality using composite of quality measures.

QVM score

75.0 / 100

Weighted average QVM score is 75.0. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.

Red Flags

No red flags found!

None of the stocks in the portfolio show significant red flags.

Frequently Asked Questions

What are the top holdings of HDFC Pharma And Healthcare Fund Direct-Growth?

The top holdings of HDFC Pharma And Healthcare Fund Direct-Growth sorted by portfolio weight are listed in the Top Portfolio Holdings section of the Holdings tab.

How many stocks does HDFC Pharma And Healthcare Fund Direct-Growth hold in its portfolio?

HDFC Pharma And Healthcare Fund Direct-Growth holds 33 securities in its portfolio. The top 5 holdings account for 33.11% of the portfolio and the top 10 for 54.54%.

What is the sector allocation of HDFC Pharma And Healthcare Fund Direct-Growth?

The sector allocation of HDFC Pharma And Healthcare Fund Direct-Growth is in the Sector Allocation section, showing each industry's weight in the portfolio.

What is the equity and debt allocation of HDFC Pharma And Healthcare Fund Direct-Growth?

As of 31 May 2026, HDFC Pharma And Healthcare Fund Direct-Growth has 98.68% in equity, 0.00% in debt and 1.32% in cash/others. This asset mix determines the fund's overall risk-return profile.

What is the market cap allocation of HDFC Pharma And Healthcare Fund Direct-Growth?

HDFC Pharma And Healthcare Fund Direct-Growth's equity portfolio — Large Cap: 27.77%, Mid Cap: 34.69%, Small Cap: 37.55%. Market cap allocation determines the fund's risk profile — large cap offers stability while mid and small cap offer higher growth potential with higher volatility.

Is HDFC Pharma And Healthcare Fund Direct-Growth a concentrated or diversified fund?

HDFC Pharma And Healthcare Fund Direct-Growth holds 33 securities, with the top 10 accounting for 54.54% of the portfolio and the top 5 for 33.11%. This is a moderately diversified fund balancing conviction positions with risk spread.

What is the credit quality of HDFC Pharma And Healthcare Fund Direct-Growth?

The credit quality breakdown of HDFC Pharma And Healthcare Fund Direct-Growth's debt portfolio is in the Credit Rating section. For equity-oriented funds, this section may not be applicable.

How often does HDFC Pharma And Healthcare Fund Direct-Growth change its portfolio?

The portfolio currently holds 33 securities with the top 10 accounting for 54.54% as of 31 May 2026. Portfolio turnover reflects how actively the fund manager trades. A high turnover increases transaction costs while a low turnover reflects a buy-and-hold approach. Historical asset allocation snapshots across multiple dates are in the Holdings Analysis section.

What is the PE ratio of HDFC Pharma And Healthcare Fund Direct-Growth's portfolio?

The weighted average PE ratio of HDFC Pharma And Healthcare Fund Direct-Growth's portfolio is 45.83 and the PB ratio is 6.02. These metrics reflect the overall valuation and interest rate sensitivity of the portfolio.

When is the latest portfolio disclosure for HDFC Pharma And Healthcare Fund Direct-Growth?

The latest portfolio disclosure for HDFC Pharma And Healthcare Fund Direct-Growth is as of 31 May 2026. Mutual funds and ETFs in India are required to disclose their full portfolio monthly, within 10 business days of month-end. You can switch between historical disclosure dates using the date selector in the Top Portfolio Holdings section.

Loading…

Asset

31 May 2026

30 Apr 2026

31 Mar 2026

28 Feb 2026

31 Jan 2026

31 Dec 2025

Equity

98.68%

97.30%

98.52%

98.22%

97.34%

97.80%

Debt

0.00%

Others (incl. cash)

1.32%

2.70%

1.48%

1.78%

2.66%

2.20%

Commodities

0.00%

Real Estate

0.00%

Instrument

Sector

No. of Shares

Value (Rs. Cr)

Weight

Change

Sun Pharmaceutical Industries Ltd.

Healthcare

12,08,549

217.44

9.20%

1.15%↑

Divis Laboratories Ltd.

Healthcare

2,84,087

189.4

8.02%

-0.54%↓

Lupin Ltd.

Healthcare

5,68,274

128.87

5.45%

-0.62%↓

Max Healthcare Institute Ltd.

Healthcare

12,88,696

124.37

5.26%

-0.67%↓

Aster DM Healthcare Ltd.

Healthcare

16,81,027

122.44

5.18%

-0.28%↓

Cipla Ltd.

Healthcare

8,30,035

116.29

4.92%

0.65%↑

Acutaas Chemicals Ltd.

Healthcare

3,39,010

106.19

4.50%

0.43%↑

Alkem Laboratories Ltd.

Healthcare

1,87,494

103.08

4.36%

-0.33%↓

Anthem Biosciences Ltd.

Healthcare

12,91,629

98.16

4.15%

-0.40%↓

Ipca Laboratories Ltd.

Healthcare

5,41,736

82.58

3.50%

-0.89%↓

Fortis Healthcare Ltd.

Healthcare

8,66,882

80.49

3.41%

-0.30%↓

Glenmark Pharmaceuticals Ltd.

Healthcare

3,40,887

77.55

3.28%

-2.78%↓

Laurus Labs Ltd.

Healthcare

5,49,343

74.82

3.17%

0.37%↑

Krishna Institute of Medical Sciences Ltd

Healthcare

9,84,676

74.72

3.16%

0.12%↑

Global Health Ltd.

Healthcare

6,11,964

72.76

3.08%

0.87%↑

Neuland Laboratories Ltd.

Healthcare

41,218

70.43

2.98%

1.01%↑

Vijaya Diagnostic Centre Ltd.

Healthcare

4,88,093

63.87

2.70%

0.15%↑

Metropolis Healthcare Ltd.

Healthcare

10,81,488

60.06

2.54%

0.15%↑

Zydus Lifesciences Ltd.

Healthcare

5,48,897

59.15

2.50%

Wockhardt Ltd.

Healthcare

2,83,279

57.55

2.44%

0.77%↑